Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,824.99
-37.6785-2.02%
Number of Gainers:4
Number of Losers:15
Number of Flat:- -
PE:- -
High:1,862.69
Open:1,861.76
Low:1,823.97
Close:1,862.66
Volume:87.22M
Turnover:8.25B
Market Cap:1.48T
Float Cap:1.45T

Loading ...

Moderna Inc Stock (MRNA) Opened Down by 6.27% on Sep 30: Key Drivers Unveiled

TradingKey
·
Sep 30

Moderna Names Juan Andres Chief Operating Officer

Dow Jones
·
Sep 30

Moderna Shares Down 7.5% After Citigroup Cuts to Sell from Neutral

THOMSON REUTERS
·
Sep 30

Abbott Launches SimpleScreen Blood Test for Colorectal Cancer

MT Newswires Live
·
Sep 30

Abbott to Release Q3 2026 Results, Host Earnings Call

Reuters
·
Sep 30

Moderna, Concentrix, Boeing, HPE, Robinhood, Cal-Maine, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 30

Abbott Launches Simplescreen™ Crc Blood Test, Joining Cologuard Plus® in Its Colorectal Cancer Screening Portfolio

THOMSON REUTERS
·
Sep 30

【US Pre-Market】Boeing Gains Nearly 3%, Moderna Slumps Pre-Market as Market Focuses on PCE and Micron Earnings

TradingKey
·
Sep 30

Moderna appoints COO as oncology expansion accelerates

TIPRANKS
·
Sep 30

It's Inflation Day and the Stock Market is on Edge

Dow Jones
·
Sep 30

Moderna Slips After Citi Downgrades to 'sell'

Reuters
·
Sep 30

Moderna appoints Juan Andres as COO

TIPRANKS
·
Sep 30

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

TIPRANKS
·
Sep 30

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Ocugen to Present 12-Month Phase 2 ArMaDa Trial Results for Ocu410 Gene Therapy in Geographic Atrophy at AAO 2026

Reuters
·
Sep 30

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS
·
Sep 30

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS
·
Sep 30

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Ocugen to Participate in Upcoming Scientific Conferences

GlobeNewswire
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30